Investigational HIV vaccine regimen shows encouraging results in non-human primates
A pre-clinical study of an HIV vaccine regimen showed complete protection from infection in half of the vaccinated non-human primates. The 'heterologous prime-boost' vaccine approach is being evaluated in a phase 1/2a clinical trial for safety and immunogenicity in healthy volunteers.